Add like
Add dislike
Add to saved papers

Treatment of Adhesive Intestinal Obstruction by Nasogastric Tube Under EnhancedRecovery After Surgery: An Efficacy Analysis.

OBJECTIVE: To explore the application value of enhanced recovery after surgery (ERAS) in the treatment of adhesive intestinal obstruction (AIO) by nasogastric tube (NGT).

METHODS: Between December 2020 and December 2022, AIO patients who received NGT treatment at The Fourth Hospital of Changsha were selected, including 43 cases receiving ERAS nursing (observation group) and 35 cases receiving routine care (control group). The two groups were compared in terms of postoperative rehabilitation, as well as their psychology, pain, and quality of life which were evaluated using Self-Rating Anxiety/Depression Scale (SAS/SDS), Visual Analogue Scale (VAS), and Short-Form 36 Item Health Survey (SF-36), respectively. During treatment, the adverse reactions were recorded.

RESULTS: In the observation group, the abdominal pain and distension relief time, time to first post-treatment flatus and defecation, abdominal circumference reduction 48 hours after admission, bowel sound recovery, first oral food intake, and extubation time were shorter than those of the control group (P < .05), and the SAS and SDS scores were also lower than those of the control group after treatment (P < .05). At 6-24 hours after treatment, the VAS of the observation group was lower than that of the control group, while the SF-36 score was higher (P < .05). Finally, a lower adverse reaction rate was determined in the observation group compared to the control group (P < .05).

CONCLUSIONS: ERAS care promotes the recovery of AIO patients after NGT treatment, improves their pain and negative emotions, improves their quality of life, and is extremely valuable for clinical application.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app